F16.921 Hallucinogen use, unspecified with intoxication with delirium

Name of the Condition

• Hallucinogen Use, Unspecified with Intoxication with Delirium
• Medical Term: ICD-10-CM F16.921

Summary

Hallucinogen use, unspecified with intoxication with delirium refers to the acute effects of hallucinogenic substance use resulting in clinically significant intoxication accompanied by delirium. This code is applied when documentation confirms recent hallucinogen exposure, intoxication symptoms, and delirium, but does not specify a problematic pattern of use beyond the acute episode. It is used for cases where intoxication with delirium is present without further classification of abuse, dependence, or withdrawal.

Causes

Hallucinogen use, unspecified with intoxication with delirium typically involves substances that alter perception, mood, or cognitive function, such as LSD, psilocybin, or mescaline. Intoxication with delirium occurs due to recent use, leading to temporary physiological and psychological effects that disrupt consciousness and cognition. The documentation does not specify a problematic pattern beyond the acute episode, but delirium is documented as a complication.

Risk Factors

• Recreational or experimental use of hallucinogens
• Pre-existing mental health conditions
• Genetic predisposition to substance use disorders
• Social or peer pressure to use drugs
• Access to hallucinogenic substances

Symptoms

• Altered sensory perceptions (e.g., visual or auditory hallucinations)
• Distorted sense of reality or time
• Mood changes, including euphoria or anxiety
• Impaired judgment or decision-making
• Confusion or disorientation
• Fluctuating level of consciousness
• Inattention or difficulty sustaining focus
• Acute agitation or restlessness
• Delirium (acute confusion, disorientation, or altered consciousness)

Diagnosis

Diagnosis requires clinical documentation of recent hallucinogen use, intoxication symptoms, and delirium. Healthcare providers assess for acute changes in mental status, cognitive impairment, and perceptual disturbances. Laboratory tests may rule out other causes of delirium, such as metabolic or infectious etiologies. The diagnosis is confirmed when the temporal relationship between hallucinogen use and delirium is established, and no other conditions better explain the symptoms.

Treatment Options

Treatment focuses on managing acute symptoms and ensuring patient safety. Supportive care, including a calm environment and monitoring, is essential. Benzodiazepines may be used for agitation, while antipsychotics address severe psychosis. Intravenous fluids and electrolyte correction may be necessary for dehydration or metabolic imbalances. In severe cases, hospitalization for observation and stabilization is required. Long-term care may involve substance use counseling or mental health support if dependence is suspected.

Prognosis and Follow-Up

Prognosis depends on the severity of delirium and underlying health. Most cases resolve with abstinence and supportive care, but delirium can persist in vulnerable individuals. Follow-up includes monitoring for recurrence of symptoms, assessing for substance use disorders, and addressing any co-occurring mental health conditions. Regular check-ins with a healthcare provider or specialist are recommended to prevent future episodes.

Complications

• Prolonged delirium or cognitive impairment
• Seizures or other neurological effects
• Psychiatric complications, such as persistent psychosis
• Accidental injury due to impaired judgment
• Worsening of pre-existing mental health conditions
• Substance use disorder development

Lifestyle & Prevention

• Avoiding hallucinogenic substances to prevent recurrence
• Seeking mental health support for substance use or co-occurring conditions
• Educating oneself on the risks of hallucinogen use
• Building a support network to reduce social pressure to use drugs
• Maintaining overall health to minimize vulnerability to delirium

When to Seek Professional Help

Seek immediate medical attention if experiencing severe confusion, hallucinations, or altered consciousness after hallucinogen use. Contact a healthcare provider for persistent symptoms, recurrent use, or concerns about substance dependence. Emergency care is necessary for life-threatening complications like seizures or severe agitation.

Tips for Medical Coders

Document the presence of hallucinogen use, intoxication, and delirium to support this code. Ensure the temporal relationship between substance use and delirium is clear. Code F16.921 is appropriate when delirium is a direct result of hallucinogen intoxication and no other complicating factors are documented. Verify that the documentation does not specify a more detailed pattern of use (e.g., abuse or dependence) to avoid miscoding.